`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`APPLE INC.,
`Petitioner,
`
`v.
`
`SMITH INTERFACE TECHNOLOGIES, LLC,
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2024-01119
`Patent 10,656,754
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S BRIEF IN SUPPORT OF BOARD’S REQUEST FOR
`COMMENT REGARDING STAYING REEXAMINATION
`
`
`
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`
`TABLE OF CONTENTS
`
`
`
`I.
`
`Introduction ....................................................................................................... 1
`
`II. There Are Overlapping Claims and Prior Art Between the Proceedings ......... 1
`
`III. The Overlap Between Proceedings Will Likely Lead to Duplicate Efforts and
`Could Result in Inconsistent Results Between Proceedings...................................... 3
`
`IV. The Respective Stages and Statutory Deadlines Between the EPRx and IPRs
`Favor a Stay ............................................................................................................... 4
`
`V. Conclusion ........................................................................................................ 5
`
`
`
`
`
`
`
`
`i
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`I.
`
`Introduction
`
`Apple submits this brief in response to the Panel’s invitation for comment
`
`regarding a potential stay of the co-pending ex parte reexamination of U.S. Patent
`
`No 10,656,754 designated Control No. 90/019,646 (hereinafter “the EPRx”). Apple
`
`does not oppose a stay of the EPRx because a stay would benefit the efficient
`
`administration of the Office and integrity of the patent system. There are
`
`overlapping issues between the instituted IPRs (IPR2024-01115, IPR2024-01116
`
`and IPR2024-01119) and the EPRx that likely will result in duplication of efforts
`
`and could result in inconsistent findings of fact and law between the proceedings
`
`absent a stay. Further, the EPRx is at an early stage such that a stay is likely to
`
`reduce the risk of duplication or waste of resources in the EPRx—a risk that only
`
`increases as the EPRx progresses. Based on these circumstances, it would be
`
`prudent and efficient to stay the EPRx pending the conclusion of the instituted IPRs.
`
`II. There Are Overlapping Claims and Prior Art Between the
`Proceedings
`
`Independent claims 2 and 225, as well as dependent claims 186 and 208, are
`
`at issue in both the instituted IPRs and the granted EPRx. Furthermore, all other
`
`claims at issue in the granted EPRx depend from either independent claim 2 or 225.
`
`Therefore, conclusions reached by the Board about the scope of independent claim
`
`2 or 225 in the IPRs will directly or indirectly impact determinations related to all of
`
`the claims at issue in the EPRx.
`
`1
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`For example, each of independent claims 2 and 225 recite the term “blur.”
`
`EX1001, cls. 2, 225. Each of dependent claims 124-127, 142, 152, 162, 165, 186,
`
`195, 198, 206, 208, 218, and 221 at issue in the EPRx also recite the term “blur.”
`
`The Petition explained that a POSITA would have understood the term “blur” to
`
`mean “make or become unclear or less distinct.” Petition at 26-27. In its preliminary
`
`response, Patent Owner explains that “Patent Owner does not agree with Petitioner’s
`
`proposed interpretation of blurring,” and “reserves the right to address Petitioner’s
`
`interpretation if IPR is instituted.” POPR at 22, n. 3. Accordingly, at least the
`
`construction of the term “blur” is at issue in both the IPRs and the EPRx.
`
`Similarly, a number of prior art references are shared between the IPRs and
`
`the EPRx. For example, U.S. Pub. No. 2010/0095240 to Shiplacoff is a prior art
`
`reference used in combinations that form grounds in each of IPR2024-01119 and the
`
`granted EPRx. Additionally, overlapping teachings from each of the following
`
`references is cited in both the IPRs and the EPRx:
`
` U.S. Appl. Pub. No. 2008/0207188 to Hye Sang Ahn et al. (“Ahn”);
` U.S. Appl. Pub. No. 2007/0150842 to Imran Chaudhri et al. (“Chaudhri
`’842”);
` Robert Kosara et al., “Semantic Depth of Field,” IEEE Symposium on
`Information Visualization 2001, pp. 97-104 (2001);
` U.S. Appl. Pub. No. 2011/0209093 to Kenneth P. Hinckley and Koji
`Yatani (“Hinkley”); and
` Certified translation of JP Published Patent Application No. 2002-
`55750 (“Hisatomi”), published February 20, 2002.
`
`2
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`The teachings from these references are utilized in both proceedings to establish the
`
`knowledge of a POSITA and demonstrate how a POSITA would understand the
`
`prior art references that form the basis of the grounds. Accordingly, interpretation
`
`of at least these numerous overlapping references will be at issue in both the IPRs
`
`and the EPRx.
`
`III. The Overlap Between Proceedings Will Likely Lead to Duplicate
`Efforts and Could Result in Inconsistent Results Between
`Proceedings
`
`Because all claims at issue in the granted EPRx depend from independent
`
`claims 2 and 225 and these independent claims are also at issue in the instituted IPRs,
`
`there is a reasonable likelihood that concurrent conduct of the granted EPRx and the
`
`instituted IPRs would lead to duplicate efforts and could result in inconsistent results
`
`between proceedings. For example, as noted above in Section II, supra, “Patent
`
`Owner does not agree with Petitioner’s proposed interpretation of blurring,” which
`
`is recited in both independent claims and numerous dependent claims at issue in the
`
`granted EPRx. POPR at 22, n. 3. Under the reasonable assumption that Patent
`
`Owner will contest the meaning of this term in the granted EPRx and the instituted
`
`IPRs, both the CRU Examiner and the Board will need to adjudicate the meaning of
`
`the term “blurring,” which would not only duplicate the effort of construing the
`
`claim language but could also lead to inconsistent results. Because Apple is no
`
`longer able to participate in the EPRx and therefore cannot appeal conclusions
`
`3
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`reached by the CRU Examiner, the Board may not have an opportunity to reverse an
`
`inconsistent conclusion regarding the term “blurring.” For example, if the Board
`
`maintains the preliminary construction of the term “blurring” it adopted in its
`
`Institution Decision (see ID at 9) in finding that the claims at issue in the IPRs are
`
`unpatentable but the CRU Examiner adopts Patent Owner’s contrary construction in
`
`finding the claims at issue in the EPRx not unpatentable, Apple will not be able to
`
`appeal the CRU Examiner’s decision and the Board will not have an opportunity to
`
`align the CRU Examiner’s decision with the Board’s.
`
`A similar possibility for duplication and inconsistency exists with respect to
`
`the scope of the prior art shared between the granted EPRx and the instituted IPRs.
`
`Both the CRU Examiner and the Board will be called upon to interpret the teachings
`
`and scope of the Shiplacoff reference. Further, the overlapping teachings cited in
`
`the various references listed in Section III, supra, are largely relied upon to
`
`corroborate the understanding of a POSITA, which will be at issue in both the
`
`granted EPRx and the instituted IPRs. Concurrent interpretation of these various
`
`references by both the Board and the CRU Examiner is both inefficient and may lead
`
`to inconsistent outcomes without a clear path for correction.
`
`IV. The Respective Stages and Statutory Deadlines Between the EPRx
`and IPRs Favor a Stay
`
`With institution of the IPRs on February 13, 2025, the Board is statutorily
`
`required to issue a final determination within 1 year. 35 U.S.C. § 316(a)(11). At
`
`4
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`most, this deadline may be extended by six months. Id. On the other hand, the only
`
`statutory deadline imposed on the EPRx—the requirement under 35 U.S.C. § 303(a)
`
`that the Director issue a determination whether the EPRx request raises a substantial
`
`new question of patentability—has been satisfied. Accordingly, a stay would violate
`
`no statutory deadlines.
`
`Further, the EPRx is at an early enough stage to avoid the inefficiencies
`
`described in Section III, supra. Specifically, the Examiner issued an order granting
`
`the EPRx on November 14, 2024. However, the Examiner has not yet issued an
`
`Office Action interpreting the claims or prior art, nor has Patent Owner filed a
`
`response arguing against those interpretations. Now is the time, early in both
`
`proceedings, at which a stay of the EPRx would best avoid any duplication of effort
`
`or inconsistencies with respect to the IPR. Furthermore, the EPRx would be
`
`simplified by the Board adjudicating the numerous overlapping issues between the
`
`two proceedings.
`
`V. Conclusion
`
`Apple does not oppose a stay of the EPRx because a stay would benefit the
`
`efficient administration of the Office and integrity of the patent system. Without a
`
`stay, there is a reasonable likelihood of duplication of efforts between the EPRx and
`
`the IPRs, and inconsistent outcomes between the two proceedings without a clear
`
`path to address those inconsistencies.
`
`5
`
`
`
`
`
`
`
`
`Dated: March 7, 2025
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/David L. Holt/
`W. Karl Renner, Reg. No. 41,265
`David L. Holt, Reg. No. 65,161
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`Tel: 202-783-5070
`Fax: 877-769-7945
`
`Counsel for Petitioner
`
`6
`
`
`
`Proceeding No.: IPR2024-01119
`Attorney Docket: 50095-0166IP7
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR § 42.6(e)(4), the undersigned certifies that on March 7,
`
`2025, a complete and entire copy of this Petitioner’s Brief in Support of Staying
`
`Reexamination was provided by email to Patent Owner by serving the email
`
`correspondence addresses of record as follows:
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eagle H. Robinson, Reg. No. 61,361
`Chad Wallis, Reg. No. 78,733
`NORTON ROSE FULBRIGHT US LLP
`98 San Jacinto Blvd., Suite 1100
`Austin, TX 78701
`eagle.robinson@nortonrosefulbright.com
`chad.wallis@nortonrosefulbright.com
`
`Daniel S. Leventhal, Reg. No. 59,576
`NORTON ROSE FULBRIGHT US LLP
`Fulbright Tower 1550 Lamar, Suite 2000
`Houston, TX 77010-3095
`daniel.leventhal@nortonrosefulbright.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Crena Pacheco/
`Crena Pacheco
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`pacheco@fr.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`



